Neurocrine Biosciences, Inc. (NBIX)
131.21
+0.25
(+0.19%)
USD |
NASDAQ |
Feb 25, 09:43
Neurocrine Biosciences Market Cap : 13.17B for Feb. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Glaukos Corp. | 6.882B |
| Edgewise Therapeutics, Inc. | 3.260B |
| Nuvalent, Inc. | 7.787B |
| Marker Therapeutics, Inc. | 27.68M |
| CapsoVision, Inc. | 236.56M |
Market Cap Related Metrics
| PE Ratio | 28.11 |
| PS Ratio | 4.698 |
| PEG Ratio | 0.6720 |
| Price to Book Value | 4.048 |
| Price to Free Cash Flow | 17.95 |
| Price | 131.21 |
| Earnings Yield | 3.56% |
| PEGY Ratio | 0.6720 |
| Operating PE Ratio | 21.11 |
| Normalized PE Ratio | 27.26 |